| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
4 companies
Levy Richard S serves as a Director at TARA and has filed Form 4s across 4 companies. Across recent SEC filings that breaks down to 23 buys and 47 sells. Those positions are worth an estimated $206K at current prices.
Historically, Levy Richard S's trades have earned a below-average insider score of 44/100 across 6 rated trades. Over a 12-month horizon, 25.0% of those trades were profitable, with an average 12-month return of -19.2%.
The biggest single holding is TARA (~$163K) as Director. Net of sales, the recent Form 4 record there shows accumulation of 20,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 21, 2017 | MDGL Madrigal Pharmaceuticals, Inc. | Director | Buy | 3,550 | $15.88 | $56,358.30 | New |